Ferring Prototypes Continuous Manufacturing with Advanced PAT and Closed-Loop Control, Potential for Dramatically Lower COGS
Ferring Pharmaceuticals, a multinational biopharmaceutical company, needed a solution that would enable faster commercialization, more cost-efficient production and reduced supply lead time while maintaining product quality in support of digitalization initiatives. The company used AspenTech’s Advanced Process Analytical Technology (PAT) solution—which includes Aspen Unscrambler™ and Aspen Process Pulse™—to address this challenge.
Read this case study to learn more about the value created by this solution.
- PAT-enabled closed-loop control ensures on-spec product quality in continuous manufacturing
- Significantly smaller footprint (continuous vs batch) saves expensive clean room space
- Real-time release testing greatly reduces delay and cost compared to offline laboratory testing
- Continuous manufacturing empowers production agility and avoids the needs for equipment scaleup
Related Content
Pharma companies continue to strive for tight control of critical quality attributes (CQAs). When Ferring Pharmaceuticals wanted to move from batch to continuous manufacturing, they found that laboratory assays were too time consuming to provide meaningful feedback for real-time control, and 100% product quality inspection was not possible.
On-Demand Webinar:
Accelerate Market Growth with New Advances in Process Analytical Technology (PAT)
White Paper:
Solution Brief: Accelerate Market Growth with New Advances in Process Analytical Technology
Video:
Optimizing Outcomes Across the Pharma Value Chain Network